The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library

Citation
F. Rae et al., The human tissue kallikreins (KLKs 1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell carcinoma cDNA library, IMMUNOPHARM, 45(1-3), 1999, pp. 83-88
Citations number
14
Categorie Soggetti
Immunology
Journal title
IMMUNOPHARMACOLOGY
ISSN journal
01623109 → ACNP
Volume
45
Issue
1-3
Year of publication
1999
Pages
83 - 88
Database
ISI
SICI code
0162-3109(199912)45:1-3<83:THTK(1>2.0.ZU;2-O
Abstract
Renal cell carcinoma (RCC) is the most common form of kidney cancer, for wh ich there is no biochemical marker. We and others have previously shown tha t a prostate specific antigen (PSA)-like protein is elevated in the serum o f women with RCC. PSA is a member of the tissue kallikrein (KLK) gene famil y of enzymes. We have constructed a RCC cDNA expression library and screene d it for PSA and KLK expression to determine whether they may be responsibl e for this PSA-like activity. Since immunoscreening of the RCC library for expressed PSA-like proteins was unsuccessful, polymerase chain reaction (PC R) analysis of the RCC cDNA library was performed using universal KLK prime rs, directed to the common regions in exon 3 and exon 5 of KLK1, KLK2 and K LK3. Sequences identical to all three KLKs were present in the RCC cDNA lib rary. In addition, a novel KLK1 transcript with a 104 base pair deletion in exon 4 that predicted a C terminal sequence minus the crucial Ser(190), wa s detected. The role of these tissue kallikreins in RCC and the significanc e of the variant KLK1 transcript is yet to be established. It is still uncl ear which of these gene products, if any, was detected in the sera of the w omen with RCC. (C) 1999 Elsevier Science B.V. All rights reserved.